350 Odcinki

  1. Episode 149: Nancy Goodman on Covid vaccines for kids, & Greg Zuckerman on Novavax's remarkable rise

    Opublikowany: 25.02.2021
  2. Episode 148: Akshay Sharma on gene therapy's setback, biotech's brashest VCs, & the FDA's future

    Opublikowany: 18.02.2021
  3. Episode 147: David Fajgenbaum on Covid-19 drugs, the state of the pandemic, & meme biotech stocks

    Opublikowany: 11.02.2021
  4. Episode 146: Paul Offit on vaccine data, 23andMe is going public, & Merck's CEO is retiring

    Opublikowany: 4.02.2021
  5. Episode 145: Kevin Davies on the CRISPR boom, & Megan Ranney on scientific misinformation

    Opublikowany: 28.01.2021
  6. Episode 144: Remembering STAT's Sharon Begley

    Opublikowany: 22.01.2021
  7. Episode 143: #JPM21: Déjà vu in Alzheimer's research, and OWS's legacy

    Opublikowany: 14.01.2021
  8. Episode 142: Bob Nelsen on the pandemic's next phase, plus Biden's biopharma plans & a CES preview

    Opublikowany: 7.01.2021
  9. Episode 141: Moderna's vaccine milestone, Warp Speed's hurdles, and biotech in 2021

    Opublikowany: 18.12.2020
  10. Episode 140: Pfizer's Covid-19 vaccine — the debate, details, and distribution

    Opublikowany: 11.12.2020
  11. Episode 139: Angela Rasmussen on AstraZeneca's confusing data, & Adam Koppel on biotech in 2021

    Opublikowany: 3.12.2020
  12. Episode 138: The latest Covid-19 vaccine, Biden's pandemic plans, and Bill Gates unfiltered

    Opublikowany: 19.11.2020
  13. Episode 137: Natalie Dean on Pfizer's Covid-19 vaccine, plus the FDA's Alzheimer's quandary

    Opublikowany: 12.11.2020
  14. Bracing for a pandemic winter, Biogen's fortune at the FDA, and remembering a remarkable 12-year-old

    Opublikowany: 5.11.2020
  15. Episode 135: Pfizer's Covid-19 mystery, Ashish Jha on pandemic response, & STAT turns 5

    Opublikowany: 29.10.2020
  16. Episode 134: Erik Gordon on SPACs, plus Covid-19 vaccines, & Biogen's case in Alzheimer's

    Opublikowany: 22.10.2020
  17. Episode 133: A week of pauses, pharma’s statehouse spending, & how HBCUs approach Covid-19 trials

    Opublikowany: 15.10.2020
  18. Episode 132: How Trump's case of Covid-19 affects biotech, medicine, and the FDA with George Scangos

    Opublikowany: 8.10.2020
  19. Episode 131: Saad Omer on Covid-19 vaccine trials, & Ethan Weiss on intermittent fasting

    Opublikowany: 1.10.2020
  20. Episode 130: A road map for Covid-19, the gold rush in health tech, & D.C.'s pandemic unrest

    Opublikowany: 24.09.2020

11 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site